Symphony Randomised Control Trial Complete
Filed with ASX · · 2 pages · English
Earlier from Aroa Biosurgery
- AROA Business Update Presentation
- AROA Business Update
- Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
- Aroa Biosurgery H1 FY26 Results
- Appendix 4D and Half Year Report
Later from Aroa Biosurgery
- ARX FY26 Preliminary Results
- FY26 Appendix 4E and Full Year Results
- FY26 Full Year Results Presentation
- Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
- Symphony Significantly Improves DFU Healing
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery